DailyDoctor Archive Specialties Get app
Back to the 24 October 2026 edition

Clinical update · 01 of 05

COVID-19, pneumococcal and influenza vaccines given together kept most antibody responses intact

Co-administering respiratory vaccines at one visit is reasonable for adults, and avoids missed second appointments.

Design
Randomised, open-label, multicentre phase 4 non-inferiority trial
Population
1,404 adults in China, half aged 60 or over
Primary outcome
Antibody titres and seroconversion after co-administration vs separate administration
Effect
Non-inferiority met for SARS-CoV-2 and pneumococcal geometric mean titres; less consistent for influenza A(H1N1) seroconversion

Adults were randomised to receive an inactivated COVID-19 vaccine with PPV23 on day 0 and with quadrivalent influenza vaccine on day 28, or to receive the vaccines separately. Equal numbers of younger and older adults took part.

Antibody responses were largely preserved with co-administration. Pneumococcal responses met non-inferiority for every serotype. Influenza A(H1N1) and the second COVID-19 dose were less consistent, and the age-stratified results should be read cautiously.

The trial supports what many immunisation programmes already allow: giving respiratory vaccines at the same visit. The specific COVID-19 vaccine used is not the one most Indian adults receive, but the principle applies to inactivated vaccines generally.

  • Antibody levels for pneumococcal serotypes and SARS-CoV-2 met non-inferiority when vaccines were given together.
  • Seroconversion was less consistent for influenza A(H1N1) and the second COVID-19 dose.
  • Mild local reactions were slightly more frequent; no vaccine-related serious events occurred.
  • Half the participants were 60 or older, the group most in need of pneumococcal and influenza vaccines.
  • Use separate limbs or sites when giving several injections at one visit.

Why it matters

Every extra visit loses patients, and older adults who most need pneumococcal and influenza vaccines are the least likely to come back.

Don't overread it

The COVID-19 vaccine was an inactivated Chinese product, and responses to influenza A(H1N1) were less consistent.

The statistics, in plain English

Non-inferiority means co-administration was not meaningfully worse than separate administration within a pre-set margin. It does not mean identical; a few endpoints did not meet the margin.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

vaccinesrespiratoryinfsepsis

Tomorrow morning, before your first patient

One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app